AOTI.LSE AOTI Inc
- Market cap
- GBX 143M
- P/E
- 67.5x
- P/B
- 9.16x
- ROE
- 13.8%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is AOTI.LSE undervalued?
Graham numberThe Graham number of AOTI Inc cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
AOTI Inc fundamental analysis
No fundamental analysis for AOTI Inc yet.
AOTI Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About AOTI Inc
AOTI, Inc., together with its subsidiaries, patents, manufacturers, rents, and sells medical devices to resolve severe acute and chronic wounds for customers worldwide. The company offers topical wound oxygen solutions for use in the institutional and the home care settings to improve the health, well-being, and independence of patients; and NEXA, a negative pressure disposable wound therapy system for use in home, acute and extended care settings. AOTI, Inc. was incorporate…
Full company profileAOTI Inc financial statements
AOTI Inc annual financial statements
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 23.0M | 33.5M | 43.9M | 58.4M | 68.8M |
| Gross Profit | 45.4K | 2.86M | 37.6M | 51.4M | 37.0M |
| Operating Income | 3.19M | -180K | -5.54M | 1.26M | 5.72M |
| EBITDA | 16.5K | 3.19M | -4.28M | 2.64M | 7.95M |
| Net Income | 2.03M | -2.80M | -8.19M | -1.76M | 2.76M |
| EPS | 0.02 | -0.03 | -0.08 | -0.02 | 0.02 |
| Balance Sheet | |||||
| Total Assets | 1.51M | 9.35M | 21.1M | 39.5M | 57.0M |
| Total Liabilities | 1.25M | 5.94M | 27.0M | 22.1M | 37.1M |
| Shareholders' Equity | 1.52M | 760K | -5.91M | 17.4M | 19.9M |
| Cash & Short-term Investments | 297K | 2.83M | 778K | 9.34M | 13.4M |
| Total Debt | 269K | 12.4M | 12.4M | 8.92M | 21.2M |
| Cash Flow | |||||
| Operating Cash Flow | -46.1K | -219K | -1.45M | -5.91M | -4.96M |
| Capital Expenditure | 382K | 999K | 1.32M | 1.94M | 1.87M |
| Free Cash Flow | -428K | 1.77M | -2.76M | -7.85M | -6.83M |
| Ratios | |||||
| ROE | 133.0% | -368.9% | - | -10.1% | 13.8% |
| ROA | 134.4% | -30.0% | -38.8% | -4.4% | 4.8% |
| Net Profit Margin | 8.8% | -8.4% | -18.6% | -3.0% | 4.0% |
| Debt to Equity | 0.18x | 16.33x | - | 0.51x | 1.06x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
AOTI Inc dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | USD 1.44M | 0.01 | - |
| 2022 | USD 5.68M | 0.05 | - |
| 2021 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns AOTI Inc
- Insiders 39.41%
- Institutions 20.44%
- Public & others 40.14%
- Shares outstanding 106M
- Free float 46.5M
AOTI Inc company profile
- Company name
- AOTI Inc
- Ticker
- AOTI.LSE
- Exchange
- London Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 90
- Fiscal year end
- December
- Address
- 3512 Seagate Way, Oceanside, CA, United States, 92056
- Phone
- 760-431-4700
- Website
- aotinc.net
About AOTI Inc
AOTI, Inc., together with its subsidiaries, patents, manufacturers, rents, and sells medical devices to resolve severe acute and chronic wounds for customers worldwide. The company offers topical wound oxygen solutions for use in the institutional and the home care settings to improve the health, well-being, and independence of patients; and NEXA, a negative pressure disposable wound therapy system for use in home, acute and extended care settings. AOTI, Inc. was incorporated in 2008 and is based in Oceanside, California.
AOTI Inc management
9- Dr. Michael Griffiths CRT, DMSPresident, CEO & Director · born 1968
- Mr. Jayesh PankhaniaCFO & Director · born 1971
- Mr. Darron DalyExecutive Vice President of Marketing & Professional Relations
- Ms. Gina So'otoExecutive Vice President of Global Human Resources
- Dr. Matthew G. Garoufalis CWS, DPM, FFPMChief Medical Officer
- Mr. David HammondPresident of Commercial International
- Mr. Marty SylvainChief Advocacy Officer
- Ms. Stacy ReelChief Commercial Officer
- Mr. Robbie WalshExecutive Vice President of Quality & Regulatory Affairs